Africa’s top public health agency (CDC) said it had signed a memorandum of understanding (MOU) with Pfizer for countries on the continent to receive supplies of the Paxlovid pill to treat COVID-19.
Data from a mid-to-late stage study last November showed the antiviral medication was nearly 90 percent effective in preventing hospitalisations and deaths compared with a placebo, in adults at high risk of severe illness.
